OLMA

SetupConviction 37LongHealthcareScan · Mon, Aug 10, 2026

Symmetrical triangletriangle

OLMA$11.95-0.83%

ResistanceSupportVol 14Insider sell

Vol MA14 878.46K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Trade plan

LongReward : Risk0.83

Entry

12.13

Risk

Stop

11.19

-7.8% to stop

Reward

Target 1

12.91

+6.5% to target

Stretch

Target 2

13.70

+12.9% to T2

Risk : reward balance

Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Olema Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.olema.com ↗

Price11.95

Change-0.83%

Gap-0.83%

Rel volume1.54×

Avg volume900.37K

Avg $ vol10.48M

SMA 2011.63

SMA 5011.32

SMA 20017.52

Price vs 50+5.53%

Price vs 200-31.81%

MA stackmixed

50/200 cross—

Supertrendup · 10.41

RSI (14)53

MACD hist0.05

MACD crossbull · 2d

Stoch %K / %D68 / 67

ADX (14)19

+DI / −DI15 / 19

RSI divergence—

MACD divergence—

ATR %+5.41%

ADR %5.33%

52w high35.83

52w low4.57

From 52w high-66.65%

Above 52w low+161.49%

New 52w highNo

SqueezeOn · 7d

Bollinger width9.09%

%B0.80

Donchian pos68.13%

Donchian high12.53

Donchian low10.71

AVWAP (52w high)17.63

vs AVWAP high-32.22%

AVWAP (52w low)18.26

vs AVWAP low-34.55%

OBV trendFlat

Chaikin MF (20)-0.13

Today vs 20d1.54×

Avg vol (14d)878.46K

Avg vol (20d)900.37K

Avg $ vol (20d)10.48M

Market cap1.05B

RS 3m (vs SPY)-26.05%

RS 6m (vs SPY)-65.93%

RS line new highNo

Trend template3/8

Technical rank29.0

1 week+5.94%

1 month+0.34%

3 months-19.80%

6 months-52.88%

1 year+153.18%

YTD-52.73%

P/E-6.44

P/B2.43

P/S—

P/FCF-7.12

EPS-1.87

Div yield—

ROE-37.73%

ROA-33.39%

Debt/Eq—

Current8.86

EV/EBITDA-5.59

Gross margin—

Net margin—

Rev growth—

EPS growth-25.47%

Price target37.83

Target upside216.57%

Analyst ratingBuy

Institutional119.41%

Ent. value997M

Revenue—

Net income-63.2M

Gross profit—

Free cash flow-146.88M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out87.35M

Employees137

ListedThu, Nov 19, 2020

Free float63.44M

Float %80.7%

Short interest15.1M

Days to cover11.3d

Short volume46.9%

Squeeze score78 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.52 vs −$0.52

Last surprise0.0% beat

Setup gradeD

Conviction37 / 100

Pattern quality50%

Tech rank29.0 / 100

Group rank86 / 100 · Leading

Status laneSetting up

Setup directionLong

Pattern familyTriangle

Resistance12.13

Support11.35

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OLMA

All disclosures →

No recent disclosed trades by Congress in OLMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OLMA · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Harmon Cyrus Director · Common Stock · 2026-07-24	Sell	12.5K	$146K	2026-07-24	2026-07-27
Harmon Cyrus Director · Common Stock · 2026-07-23	Sell	12.5K	$145K	2026-07-23	2026-07-27
Raman Prakash Director · Stock Option (Right to Buy) · 2026-04-28	Grant	24.15K	$0	2026-04-28	2026-04-29
Raman Prakash Director · Stock Option (Right to Buy) · 2026-04-28	Grant	2.91K	$0	2026-04-28	2026-04-29

SEC filings

EDGAR filings in OLMA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.